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Abstract
Background: World-wide concern about increasing antibiotic resistance has focused attention on
strategies to improve antibiotic use. This research adapted Australian best-practice guidelines on
the prophylactic use of antibiotics in surgery to a Beijing teaching hospital and then used them as a
quality assessment and improvement tool, supplemented by educational interventions. Qualitative
data about factors influencing antibiotic use was also obtained.
Methods: Australian and international guideline materials were amalgamated with the help of
Chinese experts. Antibiotics prescribed for surgical prophylaxis in 60 consecutive patients
undergoing clean or clean-contaminated surgery (120 total) were then compared with guideline
recommendations in three phases; a pre-intervention period from June to August, 2002, an
intervention period from June to August 2003 and post-intervention period from September to
November 2003. During the intervention phase, feedback about prescriptions not in accord with
the guideline was discussed with around 25 prescribers every two weeks. In addition, local factors
influencing antibiotic use were explored with 13 junior surgeons and 8 high level informants.
Results: While agreement was reached on the principles of antibiotic surgical prophylaxis there
was no consensus on detail. Of 180 patients undergoing clean surgery throughout all phases of the
study, antibiotic prophylaxis was administered to 78% compared to 98% of the 180 patients
undergoing clean-contaminated surgery. Second and third generation cephalosporin antibiotics
predominated in both low-risk clean and clean-contaminated operations. The timing of prophylaxis
was correct in virtually all patients. The duration of prophylaxis was less than 24 hours in 96% of
patients undergoing clean surgery compared to only 62% of patients undergoing clean-
contaminated surgery. The intervention produced no improvement in the duration of prophylaxis
nor the overuse and inappropriate choice of unnecessary broad-spectrum and expensive drugs.
Interviews and focus groups revealed that an important explanation for the latter problem was
Chinese government policy which expected hospitals to support themselves largely through the
sale of drugs.
Conclusion: Improving antibiotic use in China will require hospital funding reform, more
authoritative best-practice guidelines, and hospital authorities embracing quality improvement.
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Antibiotic guidelines and associated interventions have
been demonstrated to be effective in improving antibiotic
use. [1] Some countries, including Australia, have incor-
porated these principles into a national drug policy and
provided government funding for a range of activities
aimed at improving rational drug use. [2] Chinese hospi-
tals and health organizations have become interested in
such policies because of concern about inappropriate
antibiotic prescribing [3,4] and a reported increase in the
prevalence of antibiotic resistant organisms in Beijing,
Shanghai and other big cities. [5-7] Antibiotic resistance
has been described as a major threat to global public
health by the World Health Organization because there
are now few, and, in some cases, no antibiotics available
to treat certain life threatening infections. [8]
Surgeons often use prophylactic antibiotics to prevent
infection following operations and inappropriate antimi-
crobial prophylaxis is common. [9] This can be improved
by guidelines and education. [10,11] In the year 2000, the
pharmacy department of the Peking Union Medical Col-
lege Hospital (PUMCH) translated the tenth edition of
Australian Therapeutic Guidelines: Antibiotic [12] into
Chinese and made it available for sale. Although these
guidelines made recommendations for surgical prophy-
laxis, this material was simply an exact translation, it did
not involve local medical or surgical experts and the drugs
recommended were not always available locally. As a con-
sequence, this initiative was considered to have made lit-
tle impact.
This article outlines research aimed at more appropriately
adapting Australian antibiotic guidelines for surgical
prophylaxis to a Beijing hospital setting and then using
them as a quality assessment and improvement tool, sup-
plemented by educational interventions. Qualitative data
about factors influencing antibiotic use was also obtained.
Methods
Study setting
The study site was a 120 bed general surgical unit within
a 1200-bed general teaching hospital in Beijing. It was
selected because the first author was a staff member but
also because the hospital is a prestigious teaching institu-
tion, a model for other institutions and a source of influ-
ence on government policy. The attending surgeons and
house residents had responsibility for antibiotic prescrip-
tions while professors and senior doctors supervised the
junior doctor's prescriptions.
Guideline adaptation
Guideline adaptation commenced by amalgamating the
Australian material mentioned above with Chinese [13]
and other [14] material. The draft was then discussed with
Professors of the Department of Surgery, hospital phar-
macists, external microbiological experts and the hospital
manager. There was agreement on the principles of timing
(antibiotics to be administered within a two hour period
before surgery commenced) and duration (no more than
24 hours) but disagreement on specific recommendations
for particular procedures, including the recommendation
that prophylactic antibiotics are not usually necessary for
clean surgical operations. In addition, the hospital man-
ager advised that the title should be changed to "Sugges-
tion for Rational Antibiotic Use" because he felt that
"guidelines" should be written by a national team of
experts and have the approval of the Ministry of Health; a
process that was not possible in the time available.
Quantitative data collection
Quantitative data was collected from the surgical unit in
three phases; pre-intervention period from June to
August, 2002, the intervention period from June to August
2003 and the post-intervention period from September to
November 2003. In each phase, 60 patients undergoing
either clean or clean-contaminated operations were
selected (a total of 120 in each phase). Thirty consecutive
patients receiving operations for thyroid and breast dis-
ease respectively were used as representatives of clean
operations (60 clean cases) while 30 consecutive patients
receiving operations for gall bladder and gastric disease
respectively represented clean-contaminated operations
(60 clean-contaminated cases).
Detailed information was collected on patients (age, sex,
surgical diagnosis, allergy, other diseases, operation time
and complications), prescribers (age, sex, training
period,) and the antibiotics used (generic names, doses,
administrative method, timing, duration and any switch-
over to another antibiotic). In each case, the antibiotics
prescribed were compared with the agreed principles of
surgical antibiotic prophylaxis and the results tabulated.
The Chi Square test was used to analyses differences in cat-
egories of data such as the number of males and females
and antibiotics prescribed in accord or not in accord with
the agreed principles of timing and duration. The t-Test
was used to evaluate the difference between average values
for the three phases, such as age of patients, duration of
operation, etc. SPSS version 11.0 was used for data analy-
sis. A p value less than 0.05 was regarded as statistically
significant.
Educational intervention
Educational intervention was undertaken from June to
August 2003. Feedback about prescriptions not in accord
with the agreed principles was returned to around 25 pre-
scribers every two weeks and a discussion on the princi-
ples of surgical antibiotic prophylaxis as they related to
specific cases was offered to all staff interested. In addi-Page 2 of 6
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education of 13 junior surgeons about surgical antibiotic
prophylaxis. They were informed about the increased risks
of antibiotic resistance, as well as the principles and the
benefits of the rational choice of timing, duration, antibi-
otic selection. Data collection continued for three months
after educational intervention (post-intervention study
phase).
Qualitative data collection
Qualitative methods were used to collect the opinions of
high level informants and junior surgical staff about fac-
tors influencing antibiotic use. Structured interviews were
conducted with the Hospital Manager, Hospital Director
(also a council member of the State Drug Committee),
Vice Director of Pharmacy, Dean of the Surgical Depart-
ment, an official from the Ministry of Health, the Manager
of the local State Food and Drug Administration and
another council member of the State Drug Committee
(also Manager of another hospital) (a total of eight key
informants). Two focus groups were also held with a com-
bined total of 13 junior hospital surgical staff (the major-
ity of the junior surgical staff).
Results
Patients and surgeons
No statistically significant difference was found between
the patients in the pre-intervention, intervention and
post-intervention phases of the study with regard to
patients' sex, average age, average operation duration, rate
of associated disease (diabetes) and postoperative compli-
cations. Female patients predominated (70%) because
patients with breast disease were specifically selected.
There were a similar number of general surgeons involved
in the three study phases (about 26) and no significant
difference with regard to their age and the training period.
The prescribing surgeons who were exposed to the inter-
vention were the same staff who were followed up in post
intervention phase.
Timing and duration of prophylactic antibiotics
There was no significant difference between patients in
the pre-intervention, intervention and post-intervention
phases of the study regarding the timing or duration of
antibiotics used. For all groups, almost all antibiotics were
given by the intravenous route (99%) and there were a
similar number of antibiotics used per patient (average of
1.23). Almost all patients (99%) had antibiotics adminis-
tered within a two hour period prior to the commence-
ment of surgery. Almost two thirds of the patients
receiving antibiotics were given a single dose only; the
median duration of administration was 1 day, the mean
1.7 days and the range 1 to 19 days.
Because there was no statistically significant difference
between results in the control, intervention and post-
intervention groups, these were combined and then sepa-
rated into patients undergoing clean and clean-contami-
nated surgery. There was a high rate (78%) of antibiotic
prophylaxis for patients undergoing clean surgery and an
even higher rate (98%) for patients undergoing clean-con-
taminated surgery. There were no post-operative infective
complications recorded in any of the clean and clean-con-
taminated operations studied. Many more patients under-
going clean-contaminated surgery received antibiotic
prophylaxis for greater than 1 day (38%) compared to
those undergoing clean surgery (4%).
Choice of prophylactic antibiotics
In order to fairly analyze the choice of antibiotics in clean
and clean contaminated operations we excluded cases of
malignant tumour, malnutrition, diabetes, anaemia, cir-
rhosis and patients over 70 years where the surgeon may
have been concerned about an increased risk of post-oper-
ative infection. In 94 clean operations, second and third
generation cephalosporin antibiotics or the fluoroqui-
nolone levofloxacin accounted for 96% of the antibiotics
used. In 82 clean-contaminated operations, second and
third generation cephalosporin antibiotics or levofloxacin
were used in all cases; in a third of patients these drugs
were also combined with metronidazole.
Qualitative results
Interviews and focus groups provided additional informa-
tion about factors influencing antibiotic use. The trans-
lated Australian antibiotic guideline book was not
regarded as practical because its recommendations were
for generic drugs whereas the hospital drug list (and all
prescribing) used brand names. In addition, the book had
to be purchased whereas information from pharmaceuti-
cal companies was free. Table 1 summarises the major fac-
tors that respondents felt influenced antibiotic use.
Suggestions for improving antibiotic use included
improving health financing systems (including patient
compensation schemes to limit doctors being sued),
attracting support and permission from the authorized
organizations such as the Ministry of Health for develop-
ing authoritative best-practice guidelines and educational
interventions, and improving therapeutic education and
monitoring within hospitals.
Discussion
Burke [9] noted that inappropriate antimicrobial prophy-
laxis for surgical patients was common. Important errors
included delays in administering antibiotics, excessive
duration and the use of inappropriate agents. In this
study, the timing of antibiotics used for surgical prophy-
laxis was regarded as satisfactory. In all groups studied,Page 3 of 6
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two-hour period immediately before the operation (usu-
ally administered intravenously at anaesthetic induction).
With respect to duration, almost two thirds of the patients
received a single dose, while a little over three quarters
had antimicrobials administered for one day or less. How-
ever, only 62% of patients undergoing clean-contami-
nated surgery received antimicrobials for one day or less
compared to 96% undergoing clean surgery. The former is
not in accord with established guidelines. In addition,
prophylactic antibiotics were administered to 78% of low-
risk clean surgical operations and 98% of clean-contami-
nated operations; a very high use compared with other
studies. [15,16]
In most patients undergoing clean surgery the risk of
infection is very low and the guidelines we consulted did
not routinely recommend prophylactic antibiotics unless
the patient was immunosuppressed or otherwise predis-
posed to infection. In the latter situation, the most likely
contaminating micro organisms will be skin flora such as
Staphylococcus aureus and possibly Streptococcus pyo-
genes. The prophylactic antibiotic of choice will be a nar-
row-spectrum beta-lactamase stable penicillin or a first-
generation cephalosporin such as cefazolin (often
favoured because of its longer half-life). [17] However, we
found extensive use of more expensive, second and third
generation cephalosporins or fluoroquinolones whose
activity against Gram-negative organisms was unneces-
sary.
The clean-contaminated cases analysed comprised gastric
or gall bladder surgery with complications, such as
obstruction and diabetes, excluded. The risk of infection,
although higher than in clean surgery, is still low and the
likely contaminating organisms are aerobic Gram-nega-
tive organisms (in addition to skin flora). Anaerobic infec-
tion in this situation is most unlikely. However, we found
that third-generation cephalosporin antibiotics and fluor-
oquinolones, often in association with metronidazole,
were commonly used in this situation rather than second-
generation cephalosporin antibiotics recommended by
many authorities. [13,18]
The unnecessary use of extended spectrum antibiotics for
surgical prophylaxis encourages the selection of resistant
micro organisms, causes more patient adverse events and
wastes money. In particular, the use of third-generation
cephalosporins is a risk factor for infection with methicil-
lin-resistant Staphylococcus aureus, Clostridium difficile,
enterococci and resistant gram-negative bacilli. [19] These
antibiotics, along with vancomycin and metronidazole,
have been significantly associated with vancomycin-resist-
ant enterococci (VRE) [20].
The educational intervention produced no statistically sig-
nificant difference in either the duration or the timing of
antibiotics used in the pre-intervention, intervention and
post-intervention phases studied. These principles were
already being well observed (especially timing) and thus
the study lacked statistical power to detect a small added
improvement. However, other factors were also likely to
have been involved, especially in failing to shorten the
duration of prophylaxis. The Chinese researcher was rela-
tively junior and lacked influence in a hierarchal institu-
tion. Agreement could not be reached on specific
recommendations for particular procedures, including the
recommendation that prophylactic antibiotics are not
usually necessary for clean surgical operations. In addi-
tion, the hospital manager felt that "guidelines" should be
written by a national team of experts and have the
approval of the Ministry of Health; he advised that the
title should be changed to "Suggestion for Rational Anti-
biotic Use".
Table 1: Factors influencing antibiotic use in China
Factor Influence
Government policy By poorly remunerating doctors and expecting hospitals to support themselves largely 
through the sale of drugs, government policy encouraged over-prescribing of 
expensive drugs and discouraged quality assessment and improvement exercises.
Pharmaceutical industry By spending a large amount of money on drug advertising, gifts and financial "kick-
backs" to doctors who prescribed their drugs drug companies encouraged excessive 
prescribing ("kick-backs" were particularly attractive given the low salary of hospital 
doctors).
Hospital Drug and Therapeutics Committees Generally regarded as ineffective; in particular they provided no monitoring of 
prescriptions and little independent education to medical staff.
Surgeons attitude and knowledge By being less interested in drugs than physicians ("operations were more important") 
misunderstandings were perpetuated such as, "new antibiotics are stronger"; "new 
drugs kill most germs"; "the bigger the operation, the greater the need for newer and 
stronger antibiotics".
Deteriorating relationship between doctors and patients This led to doctors protecting themselves from being sued by prescribing unnecessary 
&/or expensive drugs; this practice was often acerbated by media reports of patients 
physically assaulting the medical staff &/or extorting money from hospitals when 
treatment failed.Page 4 of 6
(page number not for citation purposes)
Australia and New Zealand Health Policy 2006, 3:5 http://www.anzhealthpolicy.com/content/3/1/5Furthermore, although the educational intervention
stressed the principles of appropriate antibiotic selection,
qualitative research into the barriers to rational prescrib-
ing revealed other powerful influences that encouraged
the use of unnecessarily expensive broad-spectrum antibi-
otics; in particular the perverse effect of government pol-
icy which expected hospitals to support themselves largely
through the sale of drugs. This meant that any attempt to
produce a more discriminating use of antibiotics would
have an adverse effect on hospital finances. In addition,
prescribers had particular personal and social constraints
such as insufficient knowledge, low salary, concerns about
litigation by patients and excessive reliance on the phar-
maceutical industry (including susceptibility to "kick-
backs"), all of which shaped their attitude towards
rational antibiotic use.
Conclusion and recommendations
While this research failed in its prime aim of improving
the use of prophylactic antibiotics by surgeons in a Chi-
nese hospital it succeeded in documenting particular
problems of inappropriate antibiotic use. In addition, the
research suggested that the key determinant of this behav-
iour lies outside any particular prescriber or hospital and
relates to government policy concerning hospital financ-
ing. A pragmatic solution to the latter problem might be
to increase patient fees for medical services while lowering
the profit hospitals obtain by selling drugs. A national
campaign to inform and educate the Chinese public on
rational and economic use of medicine is also required. In
the longer term, there is a need to explore national public
insurance schemes as a better way of more equitably dis-
tributing health care costs. This would require bringing
together important stake-holders such as consumers
(through consumer organizations/civil society), health
policy makers, prescribers and the media to achieve con-
sensus and lobby the government to include national
health insurance as a policy priority. A draft national char-
ter of patients rights and responsibilities would also be a
useful campaigning tool.
Finally, there is also the need for a process, both nation-
ally and within hospitals, to facilitate clinicians reaching
agreement about evidence-based guideline recommenda-
tions, fund education campaigns to explain why guide-
lines are being introduced and conduct regular drug
utilization studies to track the quality of prescribing.
Postscript
In 2004, the Chinese Ministry of Health issued "Principles
of Clinical Antimicrobial Use Guidelines". This manual
aimed to standardize doctors' use of antibiotics and
improve treatment of bacterial infections in Chinese hos-
pitals. In November 2005, a National Workshop on
Rational Use of Antibiotics was held at the Beijing Chil-
dren's Hospital. The participants made a number of rec-
ommendations very similar to those suggested in this
paper.
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